Patient characteristics
| Characteristic . | Value . |
|---|---|
| Median age (IQR), y | 67 (53-76) |
| Stage, n (%) | |
| I-II | 48 (28.9%) |
| III-IV | 118 (71.1%) |
| IPI, n (%) | |
| 0-1 | 44 (26.5%) |
| 2 | 33 (19.9%) |
| 3 | 44 (26.5%) |
| 4-5 | 45 (27.1%) |
| COO, n (%) | |
| GC | 56 (33.7%) |
| Non-GC | 80 (48.2%) |
| Not available | 30 (18.1%) |
| LDH > ULN, n (%) | |
| Yes | 84 (57.5%) |
| No | 62 (42.5%) |
| Extranodal sites, n (%) | |
| Yes | 88 (58.3%) |
| No | 63 (41.7%) |
| Characteristic . | Value . |
|---|---|
| Median age (IQR), y | 67 (53-76) |
| Stage, n (%) | |
| I-II | 48 (28.9%) |
| III-IV | 118 (71.1%) |
| IPI, n (%) | |
| 0-1 | 44 (26.5%) |
| 2 | 33 (19.9%) |
| 3 | 44 (26.5%) |
| 4-5 | 45 (27.1%) |
| COO, n (%) | |
| GC | 56 (33.7%) |
| Non-GC | 80 (48.2%) |
| Not available | 30 (18.1%) |
| LDH > ULN, n (%) | |
| Yes | 84 (57.5%) |
| No | 62 (42.5%) |
| Extranodal sites, n (%) | |
| Yes | 88 (58.3%) |
| No | 63 (41.7%) |
COO, cell of origin; GC, germinal center; IPI, International Prognostic Index; IQR, interquartile range; LDH, lactate dehydrogenase; ULN, upper limit of normal.